Study of age, sex and body mass index wise variation in C-peptide level among urban population of Northern part of Bihar

Authors

DOI:

https://doi.org/10.18203/2349-3933.ijam20233885

Keywords:

Age, Sex, BMI, C-peptide

Abstract

Background: Different factors regulate the insulin level in blood. Earlier C-peptide was considered as by product of insulin biosynthesis and its role in body seems to be negligible. C-peptide at low physiological concentrations mimics the effects of insulin. However, in the presence of elevated level of insulin concentrations concomitant raised level of C-peptide may blunt peripheral effects of insulin age. This study was carried out to verify the age, sex, and BMI wise variation in level of C-peptide among apparently healthy individual and its contribution in fine-tuning of the tissue’s metabolism under different physiological conditions.

Methods: This is a prospective cross-sectional observational study. Estimation of serum c-peptide level was done by solid phase direct sandwich enzyme linked immunosorbent assay (ELISA) kit method. Glucose is estimated by Glucose oxidase peroxidase (GOD-POD) end point colorimetric method and HbA1C was estimated by ion exchange resin method (kit method).

Result: Serum C-peptide level is significantly high in advance age and males in compared to younger age and females respectively. The mean level of serum C-peptide is higher in higher body mass index (BMI) group compared to lower, but this difference is statistically insignificant.

Conclusions: In normal subjects, the level of C-peptide shows positive correlation with age and BMI. Males have higher level of C-peptide in comparison to females. Apart from these variation C-peptide contributes to different biological effects.

References

Shou J, Chen PJ, Xiao WH. Mechanism of increased risk of insulin resistance in aging skeletal muscle. Diabetol Metab Syndr. 2020;12(1):1-10.

Chance RE, Ellis RM, Bromer WW. Porcine proinsulin: characterization and amino acid sequence. Science. 1968;161(3837):165-7.

Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL et al. Role of C-peptide in human physiology. Am J Physiol-Endocrinol Metab. 2000;278(5):E759-68.

Ashby JP, Frier BM. Circulating C-peptide: measurement and clinical application. Ann Clin Biochem. 1981;18(3):125-30.

Piatti PM, Monti LD, Zavaroni I, Valsecchi G, Van Phan C, Costa S et al. Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes. J Clin Endocrinol Metab. 2000;85(7):2416-20.

Henriksen JH, Tronier B, Bülow JB. Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man. Metabolism. 1987;36(5):463-8.

Gale EA. Declassifying diabetes. Diabetologia. Springer; 2006;49:1989-95.

Djemli A, Gallice P, Coste T, Jannot MF, Dufayet D, Raccah D et al. Ex vivo and in vitro effects of insulin and C-peptide on Na/K ATPase activity in red blood cell membranes of type 1 diabetic patients. In: Diabetologia. Springer Verlag 175 fifth Ave, New York, NY 10010 USA. 1999;A154.

Ohtomo Y, Aperia A, Sahlgren B, Johansson BL, Wahren J. C-peptide stimulates rat renal tubular Na+, K+-ATPase activity in synergism with neuropeptide Y. Diabetologia. 1996;39(2):199-205.

Johansson BL, Linde B, Wahren J. Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992;35(12):1151-8.

Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science. 1997;277(5325):563-6.

Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diabet Med. 2000;17(3):181-9.

Ghorbani A, Omrani GR, Hadjzadeh MAR, Varedi M. Effects of rat C-peptide-II on lipolysis and glucose consumption in cultured rat adipose tissue. Exp Clin Endocrinol Diabetes. 2011;119(06):343-7.

Grunberger G, Qiang X, Li Z, Mathews ST, Sbrissa D, Shisheva A et al. Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia. 2001;44(10):1247-57.

Bhatt MP, Lim YC, Ha KS. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy. Cardiovasc Res. 2014;104(2):234-44.

Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes. 2003;52(8):1888–96.

Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350(7):664-71.

Macotela Y, Boucher J, Tran TT, Kahn CR. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes. 2009;58(4):803-12.

Mittendorfer B. Sexual dimorphism in human lipid metabolism. J Nutr. 2005;135(4):681-6.

Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6:60-75.

Garaulet M, Perez-Llamas F, Fuente T, Zamora S, Tebar FJ. Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol. 2000;143(5):657-66.

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):8607.

Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003;52(4):942-7.

Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes. 2003;52(7):1779-85.

Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459-69.

Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care. 2006;29(11):2498-503.

Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784-92.

Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest. 1988;81(2):435-41.

Chiu HK, Tsai EC, Juneja R, Stoever J, Brooks-Worrell B, Goel A et al. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77(2):237-44.

Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44(9):1094-101.

Downloads

Published

2023-12-22

Issue

Section

Original Research Articles